Search results
Feb 17, 2022 · On an adjusted basis, 2021 net income attributable to Baxter totaled $1.8 billion, or $3.61 per diluted share, an increase of 17% compared to the prior-year period. Adjusted results for full-year 2021 include a contribution to earnings of $0.08 per diluted share from Hillrom.
- Baxter Reports Fourth-Quarter and Full-Year 2022 Results
Baxter International Inc. (NYSE:BAX), a global medtech...
- Baxter Reports Fourth-Quarter and Full-Year 2022 Results
Information regarding Baxter’s recent announcements, upcoming & past events, and other useful resources for investors. Annual Reports & Proxy. Baxter's Annual Chairman Letter, Proxy Statement and Form 10-K filings sorted by year. Financial Schedules. Financial schedules and Non-GAAP reconciliations by quarter. SEC Filings
Feb 4, 2021 · For full-year 2021: Baxter expects sales growth of 7% to 8% on a reported basis and 4% to 5% on a constant currency basis. The company expects U.S. GAAP earnings of $2.91 to $2.99 per diluted share and adjusted earnings, before special items, of $3.35 to $3.43 per diluted share.
Feb 9, 2023 · Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2022, and provided its financial guidance for full-year and first-quarter 2023.
Baxter annual net income for 2022 was $-2.433B, a 289.49% decline from 2021. Baxter annual net income for 2021 was $1.284B, a 16.52% increase from 2020. Compare BAX With Other Stocks. Baxter annual/quarterly net income history and growth rate from 2010 to 2024.
Apr 28, 2022 · Baxter expects full-year 2022 sales growth of 23% to 24% on a reported basis, 25% to 26% on a constant currency basis and approximately 3% on an operational basis. Baxter expects full-year...
People also ask
How much did Baxter make in 2022?
What does Baxter expect in 2021?
What is Baxter's financial outlook for 2023?
How much did Baxter sell in 2021?
What was Baxter's net income in the fourth quarter?
What does Baxter expect in 2023?
Feb 9, 2023 · The accompanying schedules include additional details on sales performance by product categories and segments. For full-year 2022, net income (loss) attributable to Baxter totaled ($2.4 billion), or ($4.83) per diluted share on a U.S. GAAP basis.
